Adage Capital Management Files 13D for GlycoMimetics

Ticker: CBIO · Form: SC 13D · Filed: Nov 4, 2024 · CIK: 1253689

Sentiment: neutral

Topics: 13D-filing, beneficial-ownership, activist-investor

Related Tickers: GLYC

TL;DR

**Adage Capital now owns significant stake in GlycoMimetics, filing 13D.**

AI Summary

Adage Capital Management, L.P. has filed a Schedule 13D on November 4, 2024, indicating a change in beneficial ownership of GlycoMimetics, Inc. common stock. The filing details their holdings and intentions regarding the company's securities. The specific date of the event requiring this filing was October 29, 2024.

Why It Matters

This filing signals a significant investor's increased attention or change in strategy towards GlycoMimetics, potentially impacting stock price and corporate governance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate activist investor intentions or significant stake-building, which can lead to volatility and strategic shifts.

Key Players & Entities

FAQ

What is the primary purpose of this Schedule 13D filing?

The filing is to report a change in beneficial ownership of GlycoMimetics, Inc. common stock by Adage Capital Management, L.P.

Who is the filing entity and what company's stock is involved?

The filing entity is Adage Capital Management, L.P., and the stock involved is GlycoMimetics, Inc.

When was the event that triggered this filing?

The date of the event which requires filing of this statement was October 29, 2024.

What is the business address of GlycoMimetics, Inc.?

The business address of GlycoMimetics, Inc. is 9708 Medical Center Drive, Rockville, MD 20850.

Who is authorized to receive notices and communications for this filing?

Robert Atchinson of Adage Capital Partners GP, L.L.C. is authorized to receive notices and communications.

Filing Stats: 2,852 words · 11 min read · ~10 pages · Grade level 11.4 · Accepted 2024-11-04 16:26:15

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: November 4, 2024 ADAGE CAPITAL MANAGEMENT, L.P. By: Adage Capital Partners LLC, its general partner /s/ Robert Atchinson Name: Robert Atchinson Title: Managing Member /s/ Robert Atchinson ROBERT ATCHINSON, individually /s/ Phillip Gross PHILLIP GROSS, individually CUSIP No. 38000Q102 SCHEDULE 13D Page 10 of 11 Pages SCHEDULE A GENERAL PARTNERS, CONTROL PERSONS, DIRECTORS AND EXECUTIVE OFFICERS OF CERTAIN REPORTING PERSONS The following sets forth the name, position, address, principal occupation and citizenship of each general partner, control person, director and/or executive officer of the applicable Reporting Persons (the Instruction C Persons ). To the best of the Reporting Persons' knowledge, (i) none of the Instruction C Persons during the last five years has been convicted in a criminal proceeding (excluding traffic violations or other similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws and (ii) none of the Instruction C Persons owns any shares of Common Stock or is party to any contract or agreement as would require disclosure in this Schedule 13D, except to the extent such Instruction C Person is a Reporting Person in which case such Instruction C Person's beneficial REPORTING PERSON: ADAGE CAPITAL MANAGEMENT, L.P. ( ACM ) Adage Capital Partners L.L.C. ( ACPLLC ) serves as the general partner of ACM. Its business address is c/o Adage Capital Ma

View Full Filing

View this SC 13D filing on SEC EDGAR

View on Read The Filing